Longitudinal assessment of interstitial lung disease in single lung transplant recipients with scleroderma
- PMID: 31504916
- PMCID: PMC7188227
- DOI: 10.1093/rheumatology/kez341
Longitudinal assessment of interstitial lung disease in single lung transplant recipients with scleroderma
Abstract
Objective: To investigate the natural history of fibrotic lung disease in recipients of a single lung transplant for scleroderma-associated interstitial lung disease (ILD).
Methods: Global ILD (including ground glass, nodular opacities and fibrosis) was categorized into severity quintiles on first and last post-transplant CT scans, and percent fibrosis by manual contouring was also determined, in nine single lung transplant recipients. Quantitative mean lung densities and volumes for the native and allograft lungs were also acquired.
Results: In the native lung, global ILD severity quintile worsened in two cases and percent fibrosis worsened in four cases (range 5-28%). In the lung allograft, one case each developed mild, moderate and severe ILD; of these, new fibrotic ILD (involving <10% of lung) occurred in two cases and acute cellular rejection occurred in one. The average change in native lung density over time was +2.2 Hounsfield Units per year and lung volume +1.4 ml per year, whereas the allograft lung density changed by -5.5 Hounsfield Units per year and total volume +27 ml per year (P = 0.011 and P = 0.039 for native vs allograft density and volume comparisons, respectively).
Conclusions: While the course of ILD in the native and transplanted lungs varied in this series, these cases illustrate that disease progression is common in the native lung, suggesting that either the immune process continues to target autoantigens or ongoing fibrotic pathways are active in the native lung. Mild lung disease may occur in the allograft after several years due to either allograft rejection or recurrent mild ILD.
Keywords: CT imaging; interstitial lung disease; longitudinal; lung transplant; pulmonary fibrosis; scleroderma; systemic sclerosis.
© The Author(s) 2019. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For permissions, please email: journals.permissions@oup.com.
Figures


Similar articles
-
Longitudinal Changes in Quantitative Interstitial Lung Disease on Computed Tomography after Immunosuppression in the Scleroderma Lung Study II.Ann Am Thorac Soc. 2018 Nov;15(11):1286-1295. doi: 10.1513/AnnalsATS.201802-079OC. Ann Am Thorac Soc. 2018. PMID: 30265153 Free PMC article. Clinical Trial.
-
The quantitative assessment of interstitial lung disease with positron emission tomography scanning in systemic sclerosis patients.Rheumatology (Oxford). 2020 Jun 1;59(6):1407-1415. doi: 10.1093/rheumatology/kez483. Rheumatology (Oxford). 2020. PMID: 31642912 Free PMC article.
-
Differences of airway dimensions between patients with and without bronchiolitis obliterans syndrome after lung transplantation-Computer-assisted quantification of computed tomography.Eur J Radiol. 2016 Aug;85(8):1414-20. doi: 10.1016/j.ejrad.2016.05.018. Epub 2016 May 26. Eur J Radiol. 2016. PMID: 27423681
-
Diagnosis of interstitial lung disease (ILD) secondary to systemic sclerosis (SSc) and rheumatoid arthritis (RA) and identification of 'progressive pulmonary fibrosis' using chest CT: a narrative review.Clin Exp Med. 2023 Dec;23(8):4721-4728. doi: 10.1007/s10238-023-01202-1. Epub 2023 Oct 6. Clin Exp Med. 2023. PMID: 37803100 Review.
-
Novel Imaging Approaches in Systemic Sclerosis-Associated Interstitial Lung Disease.Curr Rheumatol Rep. 2019 Apr 25;21(6):25. doi: 10.1007/s11926-019-0826-9. Curr Rheumatol Rep. 2019. PMID: 31025121 Free PMC article. Review.
Cited by
-
Demystifying idiopathic interstitial pneumonia: time for more etiology-focused nomenclature in interstitial lung disease.Expert Rev Respir Med. 2022 Feb;16(2):235-245. doi: 10.1080/17476348.2022.2030710. Epub 2022 Jan 31. Expert Rev Respir Med. 2022. PMID: 35034567 Free PMC article. Review.
-
Native-lung complications following single-lung transplantation for interstitial lung disease: an in-depth analysis.BMC Pulm Med. 2024 Apr 24;24(1):202. doi: 10.1186/s12890-024-03009-6. BMC Pulm Med. 2024. PMID: 38658879 Free PMC article.
References
-
- Schurawitzki H, Stiglbauer R, Graninger W. et al. Interstitial lung disease in progressive systemic sclerosis: high-resolution CT versus radiography. Radiology 1990;176:755–9. - PubMed
-
- Steen VD, Conte C, Owens GR, Medsger TA Jr.. Severe restrictive lung disease in systemic sclerosis. Arthritis Rheum 1994;37:1283–9. - PubMed
-
- Schachna L, Medsger TA Jr, Dauber JH. et al. Lung transplantation in scleroderma compared with idiopathic pulmonary fibrosis and idiopathic pulmonary arterial hypertension. Arthritis Rheum 2006;54:3954–61. - PubMed
-
- Massad MG, Powell CR, Kpodonu J. et al. Outcomes of lung transplantation in patients with scleroderma. World J Surg 2005;29:1510–5. - PubMed
-
- Crespo MM, Bermudez CA, Dew MA. et al. Lung transplant in patients with scleroderma compared with pulmonary fibrosis. short- and long-term outcomes. Ann Am Thorac Soc 2016;13:784–92. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical